Inogen (INGN) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2026)
Inogen (INGN) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 8.20% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -30.89% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 88.89% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 47.37% |
| 10 | Inogen | 174.59 Mn | 80.18 Mn | 37.86 Mn | -20.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.00% |
| Dec 31, 2025 | 34.15% |
| Sep 30, 2025 | 20.00% |
| Jun 30, 2025 | 37.50% |
| Mar 31, 2025 | 59.68% |
| Dec 31, 2024 | 64.04% |
| Sep 30, 2024 | 87.31% |
| Jun 30, 2024 | 42.86% |
| Mar 31, 2024 | 29.55% |
| Dec 31, 2023 | 54.03% |
| Sep 30, 2023 | -369.05% |
| Jun 30, 2023 | -180.00% |
| Mar 31, 2023 | -41.94% |
| Dec 31, 2022 | -145.54% |
| Sep 30, 2022 | -179.25% |
| Jun 30, 2022 | -168.18% |
| Mar 31, 2022 | -1,966.67% |
| Dec 31, 2021 | -339.13% |
| Sep 30, 2021 | 762.50% |
| Jun 30, 2021 | 83.33% |